A new randomized, crossover clinical trial testing rapid-acting insulin aspart delivered in a closed-loop system compared with standard care demonstrates increased time in range in patients with type 2 diabetes who require dialysis in the outpatient setting.
- Charlotte K. Boughton
- Afroditi Tripyla
- Roman Hovorka
